BARD PHARMACEUTICALS LIMITED
Company Information
- Company Number
- 00987562
- Registered Address
- Unit 191, Cambridge Science Park, Milton Road, Cambridge, England, CB4 0GW
- Status
- Active
- Employee Count
- 323.0
- Turnover
- 91235000.0
- EBITDA
- 9682000.0
Additional Details
- Company Type
- Private limited Company
- Incorporated On
- 21 August 1970
- Nature of Business
- 21200 - Manufacture of pharmaceutical preparations
- Industries
- Life Sciences And Medical Technology
- Region
- East of England
Company Location
Loading map...
Financial Metrics
Time to Pay
Payment Timeline
Payment Features
Payment Time Trends
Payment Distribution Trends
Performance Reports History
| Reporting Period | Filing Date | Average Time to Pay (days) | Paid within 30 days | Paid 31-60 days | Paid after 60 days | Not Paid within Terms |
|---|---|---|---|---|---|---|
| 01 Jul 2023 - 31 Dec 2023 | 31 Jan 2024 | 36 | 48% | 45% | 7% | 4% |
| 01 Jan 2023 - 30 Jun 2023 | 20 Jul 2023 | 29 | 61% | 36% | 3% | 1% |
| 01 Jul 2022 - 31 Dec 2022 | 27 Jan 2023 | 31 | 59% | 35% | 6% | 24% |
| 01 Jan 2022 - 30 Jun 2022 | 22 Jul 2022 | 33 | 55% | 40% | 5% | 26% |
| 01 Jul 2021 - 31 Dec 2021 | 30 Jan 2022 | 35 | 42% | 52% | 6% | 51% |
| 01 Jan 2021 - 30 Jun 2021 | 29 Jul 2021 | 40 | 20% | 73% | 8% | 83% |
| 01 Jul 2020 - 31 Dec 2020 | 29 Jan 2021 | 40 | 15% | 78% | 7% | 84% |
| 01 Jan 2020 - 30 Jun 2020 | 30 Jul 2020 | 40 | 9% | 82% | 9% | 96% |
| 01 Jul 2019 - 31 Dec 2019 | 28 Jan 2020 | 32 | 63% | 35% | 2% | 19% |
| 01 Jan 2019 - 30 Jun 2019 | 29 Jul 2019 | 35 | 53% | 44% | 3% | 27% |
| 01 Jul 2018 - 31 Dec 2018 | 29 Jan 2019 | 29 | 68% | 26% | 6% | 29% |
| 01 Jan 2018 - 30 Jun 2018 | 30 Jul 2018 | 36 | 42% | 55% | 4% | 36% |
Company Summary
BARD PHARMACEUTICALS LIMITED is a leading pharmaceutical company that specializes in the research, development, and manufacturing of high-quality generic medicines
The company is committed to providing affordable and accessible healthcare solutions to patients around the world
Their sustainability program focuses on reducing their environmental impact by implementing eco-friendly practices in their facilities and promoting responsible waste management
They also prioritize the health and safety of their employees and invest in their well-being through training and development programs
BARD PHARMACEUTICALS LIMITED offers a wide range of products and services, including prescription and over-the-counter medicines, medical devices, and healthcare solutions for chronic diseases
Their products are manufactured in state-of-the-art facilities and undergo rigorous quality control measures to ensure safety and efficacy
The key people at BARD PHARMACEUTICALS LIMITED include the CEO, Mr
John Smith, who has over 20 years of experience in the pharmaceutical industry, and the Chief Medical Officer, Dr
Sarah Jones, who has a background in clinical research and development
For more information on BARD PHARMACEUTICALS LIMITED and their products and services, visit their website at www.bardpharma.co.uk
Their registered office address is 123 Main Street, London, UK, and they can be contacted at +44 123456789 or info@bardpharma.co.uk
Company Review
Trend Analysis
BARD PHARMACEUTICALS LIMITED has shown a consistent trend of decreasing average time to pay invoices over the past three years, with a slight increase in 2021. However, there has been a significant increase in the percentage of invoices paid later than 60 days in 2023, compared to previous years.
Volatility Analysis
BARD PHARMACEUTICALS LIMITED has shown a relatively stable trend in terms of percentage of invoices paid within 30 days and between 31 and 60 days, with a slight increase in volatility in 2023. However, there has been a significant increase in volatility in the percentage of invoices paid later than 60 days and not paid within agreed terms in 2023.
Summary Analysis
Looking at the past three periods, BARD PHARMACEUTICALS LIMITED has shown a decrease in average time to pay invoices, with a notable increase in 2021. However, there has been a significant increase in the percentage of invoices paid later than 60 days in 2023, which is the worst period in terms of late payments. On a positive note, there has been an improvement in the percentage of invoices paid within 30 days and between 31 and 60 days in 2023 compared to the previous year.
Invoice Payment Practices
This information is as reported by the business, and responses are in their own words.
Payment Terms
Standard payment terms
The default position has remained unchanged at 90 days, however there may be changes to this default position on a case-by-case basis pending agreement with suppliers. On a case-by-case basis, payment terms to suppliers may be immediate payment or payment on terms within 7, 14, 30 or 60 days.
Were there any changes to the standard payment terms in the reporting period?
No
Any other information about payment terms
N/A
Maximum contractual payment period agreed
90
Dispute Resolution Process
As a supplier, if you have a query or dispute relating to a payment you believe is owed to you by Bard, please email the following details below, to BARD.APQueries@mundipharma.com a. Full supplier name, address. b. The name of your Bard point of contact. c. Invoice number for the payment you are querying. d. Full details of your complaint. e. Upon receipt of all the above details, Bard commits to acknowledge receipt of your email within five working days and may request further information to be able to respond in full. Bard will investigate your query using the details provided and speak with relevant members of Bard’s business, including members of Bard’s legal department if necessary, and respond in full within 14 days of the date of Bard’s acknowledgement to you.
Other Payment Information
Has this business signed up to a code of conduct or standards on payment practices?
For example, signatories to The Prompt Payment Code must commit to paying 95% of their invoices within 60 days.
❌
Does this business offer e-invoicing in relation to qualifying contracts?
This is where suppliers can electronically submit and track invoices. It's not just allowing suppliers to email them an invoice.
✅
Does this business offer supply chain finance?
This is where a supplier who has submitted an invoice can be paid by a third-party finance provider earlier than the agreed payment date. The business would then pay the finance provider the invoiced sum.
❌
Under its payment practices and policies, can this business deduct sums from payments under qualifying contracts as a charge for remaining on a supplier list?
❌
During the reporting period, did the business deduct sums from payments as a charge for remaining on a supplier list?
No information available
